These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30928432)

  • 1. Relationship between number of contacts between previous dropouts with type 2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care.
    Kauppila T; Eriksson JG; Honkasalo M; Raina M; Laine MK
    Prim Care Diabetes; 2019 Oct; 13(5):468-473. PubMed ID: 30928432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Scand J Prim Health Care; 2016 Sep; 34(3):267-73. PubMed ID: 27404014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal follow-up study of a type 2 diabetes "lost to follow-up" cohort - positive effect on glycaemic control after changes in medication.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Int J Circumpolar Health; 2020 Jan; 79(1):1773127. PubMed ID: 32498629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study.
    Maguire A; Mitchell BD; Ruzafa JC
    BMC Endocr Disord; 2014 Aug; 14():73. PubMed ID: 25163796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of intensified clinical care on glycaemic control in patients with type 2 diabetes at Khayelitsha Community Health Centre, South Africa: Quasi-experimental study.
    Allerton J; Mash R
    Prim Care Diabetes; 2020 Apr; 14(2):97-103. PubMed ID: 31564516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol.
    Furler JS; Young D; Best J; Patterson E; O'Neal D; Liew D; Speight J; Segal L; May C; Manski-Nankervis JA; Holmes-Truscott E; Ginnivan L; Blackberry ID
    Implement Sci; 2014 Feb; 9():20. PubMed ID: 24528528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of intervention on metabolic outcomes among dropouts with type 2 diabetes.
    Laine MK; Kauppila T; Honkasalo M; Raina M; Eriksson JG
    Adv Med Sci; 2018 Mar; 63(1):5-8. PubMed ID: 28763676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela.
    G Duarte F; da Silva Moreira S; Almeida MDCC; de Souza Teles CA; Andrade CS; Reingold AL; Moreira ED
    BMJ Open; 2019 Mar; 9(3):e023401. PubMed ID: 30842107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
    Rosenstock J; Rood J; Cobitz A; Huang C; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):643-9. PubMed ID: 17026488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
    Hirst JA; Stevens RJ; Farmer AJ
    PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
    Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes.
    Lavikainen P; Aarnio E; Jalkanen K; Tirkkonen H; Rautiainen P; Laatikainen T; Martikainen J
    BMC Health Serv Res; 2020 Nov; 20(1):1095. PubMed ID: 33246453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study.
    Carrington MJ; Cohen N; Wiley JF
    Diabetes Res Clin Pract; 2017 May; 127():89-96. PubMed ID: 28324867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
    Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
    [No Abstract]   [Full Text] [Related]  

  • 19. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database.
    Aronson R; Orzech N; Ye C; Goldenberg R; Brown V
    J Diabetes; 2016 Jan; 8(1):76-85. PubMed ID: 25565383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12-month follow-up in a real-world setting in the United States.
    Mody R; Huang Q; Yu M; Zhao R; Patel H; Grabner M; Landó LF
    Diabetes Obes Metab; 2019 Apr; 21(4):920-929. PubMed ID: 30520248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.